What did @sexedtok actually say?
The creator, who claims 28 years of TRT experience, argues that endocrinologists are too conservative, often refusing to treat men with testosterone below 300 ng/dL even when symptoms are present. Their preferred target: 600 to 800 ng/dL. The core argument is that men "feel dramatically better" at higher levels, and that those higher levels are safe.
This is not a fringe position in men's health circles, but it is a contested one. The creator is essentially describing a split between symptom-driven optimization clinics and guideline-following endocrinology. Both camps have real practitioners and real patients. What they don't always have is agreement on the evidence.
Does the science back this up?
Partially, yes. The 300 ng/dL threshold used by many endocrinologists is not carved in stone by biology. It comes from guideline committees, and those committees have been criticized for being overly rigid. But the claim that 600 to 800 ng/dL is clearly safer and more effective than 400 to 500 ng/dL is much harder to defend with current trial data.
The Testosterone Trials (Snyder et al., 2016, NEJM) enrolled older men with low testosterone and found meaningful improvements in sexual function and some physical performance, but these trials normalized levels to roughly 500 ng/dL, not 700 or 800. A 2023 meta-analysis by Bhasin et al. in the Journal of Clinical Endocrinology and Metabolism found that benefits plateau at mid-normal physiologic ranges for most outcomes. The idea that higher is meaningfully better for subjective wellbeing has real anecdotal support but thin randomized trial backing. Cardiovascular risk data at higher ranges also remains genuinely unsettled, particularly after the initial TRAVERSE trial (Lincoff et al., 2023, NEJM) which showed non-inferiority for cardiac events but was conducted under specific inclusion criteria that don't apply to all patients.
What did they get wrong (or right)?
They got one thing clearly right: the 300 ng/dL cutoff for treatment is not a biological law, and symptomatic men below that threshold are often undertreated. The Endocrine Society's own 2018 guidelines acknowledge that symptoms matter alongside numbers. Dismissing a symptomatic man because his labs read 290 instead of 310 is bad medicine, and saying so plainly is fair.
What's more questionable is the framing that targeting 600 to 800 ng/dL is simply better and safe without qualification. "Safe" compared to what, in which patients, over what time horizon? The creator offers 28 years of personal clinical experience as the evidence base. That's not nothing, but it's also not a controlled study. Survivor bias in clinical experience is real: practitioners see the patients who come back, not the ones who quietly developed polycythemia, sleep apnea worsening, or stopped following up. The claim that higher levels are definitively safer is not supported by current literature and should not be taken as settled.
What should you actually know?
Testosterone reference ranges vary by lab, by age, and by the assay method used. The standard 300 to 1000 ng/dL range used by most labs reflects a population distribution, not an optimized therapeutic target. That distinction matters.
For men considering TRT, a few things are worth knowing:
- Symptoms plus labs together should drive treatment decisions. Total testosterone alone is an incomplete picture without free testosterone, SHBG, and a full symptom history.
- There is no consensus optimal target range. Guidelines suggest low-normal to mid-normal physiologic levels. Some practitioners aim higher. Neither approach has a definitive long-term outcomes trial behind it.
- Monitoring matters more than the target. Hematocrit, PSA, blood pressure, and symptom tracking are not optional extras. They're how you catch problems before they become serious.
- The TRAVERSE trial (Lincoff et al., 2023, NEJM) provided some reassurance on cardiovascular risk in middle-aged to older men, but it was not designed to evaluate high-normal versus mid-normal targets specifically.
Anyone watching this video and thinking "my doctor won't treat me, I should find someone who will target 700" should slow down. The goal is to find a clinician who will evaluate you completely, not one whose approach is simply more aggressive by default.
Bottom line: is this advice you should follow?
The creator raises a legitimate critique of overly rigid endocrinology gatekeeping. That part lands. But "aggressive" as a clinical philosophy, presented without discussion of monitoring protocols, patient selection, or individual risk factors, is incomplete and in some cases could be harmful. Experience is valuable. It is not a substitute for individualized evaluation and informed consent about what the evidence actually shows, and what it doesn't.